FDA Approves Unknown Drug — MICRO LABS

# FDA Approves New Generic Drug Application for Micro Labs Micro Labs received FDA approval for ANDA220104 on May 19, 2026, expanding its generic pharmaceutical portfolio and positioning the company to capture additional market share in the competitive generic drug sector. The approval is expected to enhance Micro Labs' revenue streams and strengthen its presence in the U.S. market, where generic medications continue to drive cost savings for patients and payers.